Published in Environ Health Perspect on June 07, 2013
Urinary cadmium as a marker of exposure in epidemiological studies. Environ Health Perspect (2013) 0.92
Dietary cadmium exposure and risk of breast, endometrial, and ovarian cancer in the Women's Health Initiative. Environ Health Perspect (2014) 0.91
Confusion about Cadmium Risks: The Unrecognized Limitations of an Extrapolated Paradigm. Environ Health Perspect (2015) 0.83
Dietary Intake Estimates and Urinary Cadmium Levels in Danish Postmenopausal Women. PLoS One (2015) 0.80
Cadmium and Reproductive Health in Women: A Systematic Review of the Epidemiologic Evidence. Curr Environ Health Rep (2014) 0.78
Geriatric study in Europe on health effects of air quality in nursing homes (GERIE study) profile: objectives, study protocol and descriptive data. Multidiscip Respir Med (2013) 0.77
Human exposure and risk assessment of cadmium for residents of abandoned metal mine areas in Korea. Environ Geochem Health (2014) 0.77
Renal tubular dysfunction increases mortality in the Japanese general population living in cadmium non-polluted areas. J Expo Sci Environ Epidemiol (2014) 0.76
Cadmium and Alzheimer's disease mortality in U.S. adults: Updated evidence with a urinary biomarker and extended follow-up time. Environ Res (2017) 0.75
Urinary cadmium as a marker of exposure in epidemiological studies: Bernard and Chaumont respond. Environ Health Perspect (2013) 0.75
Association of cadmium with diabetes in middle-aged residents of abandoned metal mines: the first health effect surveillance for residents in abandoned metal mines. Ann Occup Environ Med (2015) 0.75
Human biomonitoring of heavy metals in the vicinity of non-ferrous metal plants in Ath, Belgium. Arch Public Health (2016) 0.75
Cadmium exposure in inhabitants living in non-polluted area. J Expo Sci Environ Epidemiol (2015) 0.75
Urinary Cadmium and Risk of Invasive Breast Cancer in the Women's Health Initiative. Am J Epidemiol (2016) 0.75
Dietary predictors of urinary cadmium among pregnant women and children. Sci Total Environ (2016) 0.75
Temporal variability of urinary cadmium in spot urine samples and first morning voids. J Expo Sci Environ Epidemiol (2016) 0.75
Is Urinary Cadmium a Biomarker of Long-term Exposure in Humans? A Review. Curr Environ Health Rep (2016) 0.75
Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect (2005) 8.62
Endogenous creatinine in serum and urine. Proc Soc Exp Biol Med (1950) 6.44
Current status of cadmium as an environmental health problem. Toxicol Appl Pharmacol (2009) 4.85
Renal effects of cadmium body burden of the general population. Lancet (1990) 2.90
In vivo measurement of liver and kidney cadmium in workers exposed to this metal: its significance with respect to cadmium in blood and urine. Environ Res (1981) 1.81
Associations of low-level urine cadmium with kidney function in lead workers. Occup Environ Med (2010) 1.67
Continuous-flow system for automation of latex immunoassay by particle counting. Clin Chem (1983) 1.52
Dioxin/polychlorinated biphenyl body burden, diabetes and endometriosis: findings in a population-based study in Belgium. Biomarkers (2004) 1.44
Population toxicokinetic modeling of cadmium for health risk assessment. Environ Health Perspect (2009) 1.26
Associations between urinary excretion of cadmium and proteins in a nonsmoking population: renal toxicity or normal physiology? Environ Health Perspect (2012) 1.24
The critical level of cadmium in human renal cortex: a reevaluation. Toxicol Lett (1983) 1.23
Confounders in the assessment of the renal effects associated with low-level urinary cadmium: an analysis in industrial workers. Environ Health (2011) 1.21
Cadmium and the kidney. Environ Health Perspect (1984) 1.20
Associations between proteins and heavy metals in urine at low environmental exposures: evidence of reverse causality. Toxicol Lett (2012) 1.16
Interpreting NHANES biomonitoring data, cadmium. Toxicol Lett (2010) 1.12
Infant swimming in chlorinated pools and the risks of bronchiolitis, asthma and allergy. Eur Respir J (2010) 1.07
Health effects of environmental exposure to cadmium: objectives, design and organization of the Cadmibel Study: a cross-sectional morbidity study carried out in Belgium from 1985 to 1989. Environ Health Perspect (1990) 1.07
The threshold level of urinary cadmium associated with increased urinary excretion of retinol-binding protein and beta 2-microglobulin: a re-assessment in a large cohort of nickel-cadmium battery workers. Occup Environ Med (2010) 1.05
Outdoor swimming pools and the risks of asthma and allergies during adolescence. Eur Respir J (2008) 1.02
Internal exposure to pollutants and body size in Flemish adolescents and adults: associations and dose-response relationships. Environ Int (2010) 0.98
Urinary cadmium as indicator of renal cadmium in humans: an autopsy study. Hum Exp Toxicol (1998) 0.97
Levels of cadmium in kidney and liver tissues among a Canadian population (province of Québec). J Toxicol Environ Health A (1999) 0.94
Urinary levels of arsenic and heavy metals in children and adolescents living in the industrialised area of Ria of Huelva (SW Spain). Environ Int (2010) 0.94
Smoking-induced increase in urinary cadmium levels among Japanese women. Int Arch Occup Environ Health (2005) 0.93
Human biomonitoring of cadmium and lead exposure of child-mother pairs from Germany living in the vicinity of industrial sources (hot spot study NRW). J Trace Elem Med Biol (2005) 0.88
The association between urinary kidney injury molecule 1 and urinary cadmium in elderly during long-term, low-dose cadmium exposure: a pilot study. Environ Health (2011) 0.88
Cadmium in kidney cortex of inhabitants of North-West Germany: its relationship to age, sex, smoking and environmental pollution by cadmium. Int Arch Occup Environ Health (1987) 0.79
Cadmium levels in kidney cortex in Swedish farmers. Environ Res (2000) 0.78
Risks of new-onset allergic sensitization and airway inflammation after early age swimming in chlorinated pools. Int J Hyg Environ Health (2013) 0.78
Treatment of hypertension in patients 80 years of age or older. N Engl J Med (2008) 21.04
Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA (2011) 8.83
Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation (2006) 7.01
European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens (2003) 5.94
Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet (2007) 5.21
Working Group on Blood Pressure Monitoring of the European Society of Hypertension International Protocol for validation of blood pressure measuring devices in adults. Blood Press Monit (2002) 4.02
The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med (2002) 3.61
Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension (2007) 3.57
Ambulatory arterial stiffness index as a predictor of cardiovascular mortality in the Dublin Outcome Study. Hypertension (2006) 3.42
Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens (2005) 3.15
Masked hypertension in diabetes mellitus: treatment implications for clinical practice. Hypertension (2013) 2.89
Environmental exposure to cadmium and risk of cancer: a prospective population-based study. Lancet Oncol (2006) 2.88
Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003. J Hypertens (2003) 2.71
Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations. Hypertension (2010) 2.64
Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation (2007) 2.59
Angiotensin-converting enzyme inhibitors and calcium channel blockers for coronary heart disease and stroke prevention. Hypertension (2005) 2.54
Obesity is associated with increased arterial stiffness from adolescence until old age. J Hypertens (2005) 2.47
Ambulatory blood pressure monitoring in 9357 subjects from 11 populations highlights missed opportunities for cardiovascular prevention in women. Hypertension (2011) 2.33
Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens (2010) 2.28
Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7,030 individuals. J Hypertens (2007) 2.26
Predictive role of the nighttime blood pressure. Hypertension (2010) 2.07
Prevalence of left ventricular diastolic dysfunction in a general population. Circ Heart Fail (2009) 2.03
Sexual maturation in relation to polychlorinated aromatic hydrocarbons: Sharpe and Skakkebaek's hypothesis revisited. Environ Health Perspect (2002) 2.03
Renal and neurologic effects of cadmium, lead, mercury, and arsenic in children: evidence of early effects and multiple interactions at environmental exposure levels. Environ Health Perspect (2006) 2.02
Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome. Hypertension (2014) 1.97
Genomewide association study using a high-density single nucleotide polymorphism array and case-control design identifies a novel essential hypertension susceptibility locus in the promoter region of endothelial NO synthase. Hypertension (2011) 1.89
Pulmonary epithelial integrity in children: relationship to ambient ozone exposure and swimming pool attendance. Environ Health Perspect (2004) 1.87
On-treatment diastolic blood pressure and prognosis in systolic hypertension. Arch Intern Med (2007) 1.75
Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population. J Hypertens (2003) 1.74
Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies. Hypertension (2009) 1.74
Blood pressure reduction and cardiovascular prevention: an update including the 2003-2004 secondary prevention trials. Hypertens Res (2005) 1.73
Independent relations of left ventricular structure with the 24-hour urinary excretion of sodium and aldosterone. Hypertension (2009) 1.69
Prognostic significance of renal function in elderly patients with isolated systolic hypertension: results from the Syst-Eur trial. J Am Soc Nephrol (2002) 1.68
Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference. Ther Drug Monit (2009) 1.68
Meta-analysis of continuous outcomes combining individual patient data and aggregate data. Stat Med (2008) 1.65
A new functional CYP3A4 intron 6 polymorphism significantly affects tacrolimus pharmacokinetics in kidney transplant recipients. Clin Chem (2011) 1.64
Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature. Hypertens Res (2009) 1.63
Natural rubber latex allergy among health care workers: a systematic review of the evidence. J Allergy Clin Immunol (2006) 1.63
Maternal personal exposure to airborne benzene and intrauterine growth. Environ Health Perspect (2009) 1.59
Blood pressure and blood selenium: a cross-sectional and longitudinal population study. Eur Heart J (2007) 1.58
Reference values in white Europeans for the arterial pulse wave recorded by means of the SphygmoCor device. Hypertens Res (2006) 1.56
Acute barium intoxication and hemodiafiltration. J Toxicol Clin Toxicol (2003) 1.55
Epistatic interaction between alpha- and gamma-adducin influences peripheral and central pulse pressures in white Europeans. J Hypertens (2005) 1.55
Implications of recently published trials of blood pressure-lowering drugs in hypertensive or high-risk patients. Hypertension (2010) 1.55
Increased pulse pressure linked to dementia: further results from the Hypertension in the Very Elderly Trial - HYVET. J Hypertens (2013) 1.53
In-hospital mortality among black patients admitted for hypertension-related disorders in Mbuji Mayi, Congo. Am J Hypertens (2009) 1.52
Cord blood Clara cell protein CC16 predicts the development of bronchopulmonary dysplasia. Eur J Pediatr (2008) 1.51
Biomarkers of Mn exposure in humans. Am J Ind Med (2007) 1.51
Estimating the health effects of exposure to multi-pollutant mixture. Ann Epidemiol (2012) 1.50
Outcome-driven thresholds for ambulatory pulse pressure in 9938 participants recruited from 11 populations. Hypertension (2013) 1.50
Risk stratification by 24-hour ambulatory blood pressure and estimated glomerular filtration rate in 5322 subjects from 11 populations. Hypertension (2012) 1.49
Cardiovascular outcome in relation to progression to hypertension in the Copenhagen MONICA cohort. Am J Hypertens (2007) 1.48
Determinants of the ambulatory arterial stiffness index in 7604 subjects from 6 populations. Hypertension (2008) 1.48
Responses of the ambulatory arterial stiffness index and other measures of arterial function to antihypertensive drugs. Hypertens Res (2011) 1.47
Does childhood immunization against infectious diseases protect from the development of atopic disease? Pediatr Allergy Immunol (2005) 1.46
Donor age and ABCB1 1199G>A genetic polymorphism are independent factors affecting long-term renal function after kidney transplantation. J Surg Res (2012) 1.45
Blood pressure load does not add to ambulatory blood pressure level for cardiovascular risk stratification. Hypertension (2014) 1.44
Doppler indexes of left ventricular systolic and diastolic function in relation to the arterial stiffness in a general population. J Hypertens (2016) 1.44
Modulation of aquaporin-2/vasopressin2 receptor kidney expression and tubular injury after endotoxin (lipopolysaccharide) challenge. Crit Care Med (2008) 1.44
Adverse health effects of child labor: high exposure to chromium and oxidative DNA damage in children manufacturing surgical instruments. Environ Health Perspect (2012) 1.44
Nonmalignant respiratory effects of chronic arsenic exposure from drinking water among never-smokers in Bangladesh. Environ Health Perspect (2008) 1.44
Dioxin/polychlorinated biphenyl body burden, diabetes and endometriosis: findings in a population-based study in Belgium. Biomarkers (2004) 1.44
Effects of genetic variation in adducin on left ventricular diastolic function as assessed by tissue Doppler imaging in a Flemish population. J Hypertens (2008) 1.42
Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Arch Intern Med (2002) 1.42
Reproducibility of the ambulatory arterial stiffness index in hypertensive patients. J Hypertens (2008) 1.40
White-coat hypertension: new insights from recent studies. Hypertension (2013) 1.39
Renal function after reduction in cadmium exposure: an 8-year follow-up of residents in cadmium-polluted areas. Environ Health Perspect (2011) 1.39
Blood pressure lowering for primary and secondary prevention of stroke. Hypertension (2006) 1.38
Renal denervation: ultima ratio or standard in treatment-resistant hypertension. Hypertension (2012) 1.35
Prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations. Hypertension (2010) 1.35
Cadmium biomonitoring and renal dysfunction among a population environmentally exposed to cadmium from smelting in China (ChinaCad). Biometals (2002) 1.28
Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. Carcinogenesis (2004) 1.28
Prognostic significance of electrocardiographic voltages and their serial changes in elderly with systolic hypertension. Hypertension (2004) 1.27
Effect of a new functional CYP3A4 polymorphism on calcineurin inhibitors' dose requirements and trough blood levels in stable renal transplant patients. Pharmacogenomics (2011) 1.27
Ambulatory arterial stiffness index and 24-hour ambulatory pulse pressure as predictors of mortality in Ohasama, Japan. Stroke (2007) 1.25
Cadmium-related mortality and long-term secular trends in the cadmium body burden of an environmentally exposed population. Environ Health Perspect (2008) 1.24
Bone resorption and environmental exposure to cadmium in women: a population study. Environ Health Perspect (2008) 1.24
Left ventricular strain and strain rate in a general population. Eur Heart J (2008) 1.24
Allergic rhinitis and its consequences on quality of sleep: An unexplored area. Arch Intern Med (2006) 1.23
CYP3A4*22: promising newly identified CYP3A4 variant allele for personalizing pharmacotherapy. Pharmacogenomics (2013) 1.21
Sirolimus and tacrolimus trough concentrations and dose requirements after kidney transplantation in relation to CYP3A5 and MDR1 polymorphisms and steroids. Transplantation (2005) 1.21
Confounders in the assessment of the renal effects associated with low-level urinary cadmium: an analysis in industrial workers. Environ Health (2011) 1.21
Lung epithelial injury markers are not influenced by use of lower tidal volumes during elective surgery in patients without preexisting lung injury. Am J Physiol Lung Cell Mol Physiol (2007) 1.19
Two novel, severe asthma phenotypes identified during childhood using a clustering approach. Eur Respir J (2012) 1.19
Angiotensin-converting enzyme I/D and alpha-adducin Gly460Trp polymorphisms: from angiotensin-converting enzyme activity to cardiovascular outcome. Hypertension (2007) 1.17
Associations between proteins and heavy metals in urine at low environmental exposures: evidence of reverse causality. Toxicol Lett (2012) 1.16
Cardiovascular risk in white-coat and sustained hypertensive patients. Blood Press (2002) 1.16
Subclinical responses in healthy cyclists briefly exposed to traffic-related air pollution: an intervention study. Environ Health (2010) 1.15
Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily. Hum Genomics (2011) 1.13
Low bone density and renal dysfunction following environmental cadmium exposure in China. Ambio (2002) 1.12
High human exposure to cobalt and other metals in Katanga, a mining area of the Democratic Republic of Congo. Environ Res (2009) 1.12
Home blood pressure variability as cardiovascular risk factor in the population of Ohasama. Hypertension (2012) 1.11
Exhaled metallic elements and serum pneumoproteins in asymptomatic smokers and patients with COPD or asthma. Chest (2006) 1.10
Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Blood Press Monit (2007) 1.09
The new CYP3A4 intron 6 C>T polymorphism (CYP3A4*22) is associated with an increased risk of delayed graft function and worse renal function in cyclosporine-treated kidney transplant patients. Pharmacogenet Genomics (2012) 1.09
First-in-man randomized clinical trial of renal denervation for atrial arrhythmia raises concern. J Am Coll Cardiol (2013) 1.09
Novel CYP3A4 intron 6 single nucleotide polymorphism is associated with simvastatin-mediated cholesterol reduction in the Rotterdam Study. Pharmacogenet Genomics (2011) 1.09
Changes in serum pneumoproteins caused by short-term exposures to nitrogen trichloride in indoor chlorinated swimming pools. Biomarkers (2003) 1.08